Symbols / KRMD Stock $3.99 -2.92% KORU Medical Systems, Inc.
KRMD (Stock) Chart
About
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Stock Fundamentals
Scroll to Statements| Market Cap | 185.59M | Enterprise Value | 185.21M | Income | -2.64M | Sales | 41.13M | Book/sh | 0.37 | Cash/sh | 0.19 |
| Dividend Yield | — | Payout | 0.00% | Employees | 73 | IPO | — | P/E | — | Forward P/E | 46.94 |
| PEG | — | P/S | 4.51 | P/B | 10.84 | P/C | — | EV/EBITDA | -81.24 | EV/Sales | 4.50 |
| Quick Ratio | 1.88 | Current Ratio | 2.44 | Debt/Eq | 20.51 | LT Debt/Eq | — | EPS (ttm) | -0.06 | EPS next Y | 0.09 |
| EPS Growth | — | Revenue Growth | 23.30% | Earnings | 2026-05-06 | ROA | -6.71% | ROE | -15.58% | ROIC | — |
| Gross Margin | 62.26% | Oper. Margin | -5.02% | Profit Margin | -6.41% | Shs Outstand | 46.51M | Shs Float | 27.86M | Short Float | 2.33% |
| Short Ratio | 4.97 | Short Interest | — | 52W High | 6.61 | 52W Low | 2.35 | Beta | 0.54 | Avg Volume | 189.67K |
| Volume | 105.87K | Target Price | $6.80 | Recom | Strong_buy | Prev Close | $4.11 | Price | $3.99 | Change | -2.92% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-13 | main | Canaccord Genuity | Buy → Buy | $6 |
| 2026-03-13 | main | B. Riley Securities | Buy → Buy | $8 |
| 2025-12-22 | main | Lake Street | Buy → Buy | $8 |
| 2025-12-17 | main | Canaccord Genuity | Buy → Buy | $6 |
| 2025-08-07 | main | Piper Sandler | Neutral → Neutral | $4 |
| 2025-05-08 | main | Piper Sandler | Neutral → Neutral | $4 |
| 2025-02-14 | down | Piper Sandler | Overweight → Neutral | $5 |
| 2025-01-17 | main | Craig-Hallum | Buy → Buy | $6 |
| 2025-01-14 | main | Lake Street | Buy → Buy | $5 |
| 2024-11-14 | main | Craig-Hallum | Buy → Buy | $5 |
| 2024-11-14 | main | Canaccord Genuity | Buy → Buy | $4 |
| 2024-11-14 | main | Piper Sandler | Overweight → Overweight | $4 |
| 2024-08-08 | main | Piper Sandler | Overweight → Overweight | $3 |
| 2024-03-14 | reit | B. Riley Securities | Buy → Buy | $4 |
| 2023-12-07 | reit | Canaccord Genuity | Buy → Buy | $3 |
| 2023-09-07 | init | Lake Street | — → Buy | $4 |
| 2023-09-07 | init | B. Riley Securities | — → Buy | $5 |
| 2023-08-03 | main | Piper Sandler | Overweight → Overweight | $3 |
| 2023-01-06 | main | Piper Sandler | — → Overweight | $5 |
| 2022-11-10 | up | Canaccord Genuity | Hold → Buy | $4 |
- KRMD (KORU Medical Systems Inc.) rises 3.59 percent after posting narrower than expected Q4 2025 per share loss. - Viral Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 01
- KORU Medical to hold Q1 results call May 6 at 4:30 p.m. ET - Stock Titan hu, 16 Apr 2026 12
- KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Shares Climb 34% But Its Business Is Yet to Catch Up - simplywall.st Wed, 17 Dec 2025 08
- Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround - Yahoo Finance hu, 12 Feb 2026 08
- KRMD (KORU Medical Systems Inc.) beats Q4 2025 EPS expectations, posts 22 percent YoY revenue growth, shares dip 1.16 percent. - Performance Review - Xã Vĩnh Công Wed, 22 Apr 2026 19
- KRMD (KORU Medical Systems Inc.) beats Q4 2025 EPS expectations, posts 22 percent YoY revenue growth, shares dip 1.16 percent. - Earnings Miss - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 21
- Major KRMD holder Horton Capital fund granted 3,472 KORU Medical shares - Stock Titan Mon, 06 Apr 2026 07
- KORU Medical Systems Inc (KRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance Wed, 12 Nov 2025 08
- Director Matin Shahriar receives 3,472 KRMD shares in equity grant at KORU Medical (KRMD) - Stock Titan Wed, 01 Apr 2026 07
- KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance hu, 12 Mar 2026 07
- Donna French of KORU Medical Systems (KRMD) receives 3,472-share stock grant - Stock Titan Wed, 01 Apr 2026 07
- Is KORU (KRMD) Stock Near a Bottom | Price at $4.34, Up 0.46% - Stock Accumulation - Cổng thông tin điện tử tỉnh Lào Cai Mon, 06 Apr 2026 07
- All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy - Yahoo Finance Wed, 21 Jan 2026 08
- Director Edward Wholihan receives 3,472 KRMD shares in Form 4 award - Stock Titan Wed, 01 Apr 2026 07
- Insider group in KORU Medical Systems (KRMD) awarded 3,472 shares - Stock Titan Wed, 01 Apr 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
41.13
+22.23%
|
33.65
+17.98%
|
28.52
+2.23%
|
27.90
|
| Operating Revenue |
|
41.13
+22.23%
|
33.65
+17.98%
|
28.52
+2.23%
|
27.90
|
| Cost Of Revenue |
|
15.52
+26.06%
|
12.31
+4.28%
|
11.81
-5.73%
|
12.53
|
| Reconciled Cost Of Revenue |
|
15.52
+26.06%
|
12.31
+4.28%
|
11.81
-5.73%
|
12.53
|
| Gross Profit |
|
25.60
+20.03%
|
21.33
+27.67%
|
16.71
+8.71%
|
15.37
|
| Operating Expense |
|
28.58
+2.87%
|
27.78
+2.96%
|
26.98
+3.17%
|
26.15
|
| Research And Development |
|
4.39
-16.56%
|
5.26
-8.43%
|
5.74
+15.86%
|
4.96
|
| Selling General And Administration |
|
23.38
+8.08%
|
21.63
+6.22%
|
20.37
-1.17%
|
20.61
|
| Total Expenses |
|
44.10
+9.99%
|
40.09
+3.36%
|
38.79
+0.29%
|
38.68
|
| Operating Income |
|
-2.97
+53.89%
|
-6.45
+37.23%
|
-10.27
+4.74%
|
-10.78
|
| Total Operating Income As Reported |
|
-2.97
+53.89%
|
-6.45
+37.23%
|
-10.27
+4.74%
|
-10.78
|
| EBITDA |
|
-2.16
+61.10%
|
-5.56
+40.87%
|
-9.40
+7.79%
|
-10.19
|
| Normalized EBITDA |
|
-2.22
+59.81%
|
-5.51
+40.95%
|
-9.33
+8.07%
|
-10.15
|
| Reconciled Depreciation |
|
0.81
-8.78%
|
0.89
+2.08%
|
0.87
+48.24%
|
0.59
|
| EBIT |
|
-2.97
+53.89%
|
-6.45
+37.23%
|
-10.27
+4.74%
|
-10.78
|
| Total Unusual Items |
|
0.05
+215.45%
|
-0.05
+29.17%
|
-0.06
-62.84%
|
-0.04
|
| Total Unusual Items Excluding Goodwill |
|
0.05
+215.45%
|
-0.05
+29.17%
|
-0.06
-62.84%
|
-0.04
|
| Special Income Charges |
|
—
|
-0.02
+72.98%
|
-0.06
|
0.00
|
| Net Income |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Pretax Income |
|
-2.62
+56.86%
|
-6.06
+37.96%
|
-9.77
+8.45%
|
-10.68
|
| Net Non Operating Interest Income Expense |
|
0.29
-34.01%
|
0.44
-20.79%
|
0.56
+285.56%
|
0.15
|
| Net Interest Income |
|
0.29
-34.01%
|
0.44
-20.79%
|
0.56
+285.56%
|
0.15
|
| Interest Income Non Operating |
|
0.29
-34.01%
|
0.44
-20.79%
|
0.56
+285.56%
|
0.15
|
| Interest Income |
|
0.29
-34.01%
|
0.44
-20.79%
|
0.56
+285.56%
|
0.15
|
| Other Income Expense |
|
0.06
+201.37%
|
-0.06
+4.28%
|
-0.06
-62.84%
|
-0.04
|
| Other Non Operating Income Expenses |
|
0.01
+161.30%
|
-0.02
|
—
|
—
|
| Gain On Sale Of Security |
|
0.05
+215.45%
|
-0.05
-797.56%
|
-0.01
+87.15%
|
-0.04
|
| Tax Provision |
|
0.02
+656.65%
|
0.00
-99.93%
|
3.97
+296.99%
|
-2.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+11.31%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.01
+215.45%
|
-0.01
+29.17%
|
-0.01
-81.26%
|
-0.01
|
| Net Income Including Noncontrolling Interests |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Net Income From Continuing And Discontinued Operation |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Net Income Continuous Operations |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Normalized Income |
|
-2.68
+55.56%
|
-6.03
+55.95%
|
-13.69
-58.65%
|
-8.63
|
| Net Income Common Stockholders |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Diluted EPS |
|
-0.06
+53.85%
|
-0.13
+56.67%
|
-0.30
-57.89%
|
-0.19
|
| Basic EPS |
|
-0.06
+53.85%
|
-0.13
+56.67%
|
-0.30
-57.89%
|
-0.19
|
| Basic Average Shares |
|
46.19
+0.84%
|
45.80
+0.44%
|
45.60
+1.33%
|
45.00
|
| Diluted Average Shares |
|
46.19
+0.84%
|
45.80
+0.44%
|
45.60
+1.33%
|
45.00
|
| Diluted NI Availto Com Stockholders |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Depreciation Amortization Depletion Income Statement |
|
0.81
-8.78%
|
0.89
+2.08%
|
0.87
+48.24%
|
0.59
|
| Depreciation And Amortization In Income Statement |
|
0.81
-8.78%
|
0.89
+2.08%
|
0.87
+48.24%
|
0.59
|
| Gain On Sale Of PPE |
|
—
|
-0.02
+72.98%
|
-0.06
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
28.20
+3.61%
|
27.22
-4.37%
|
28.46
-32.77%
|
42.33
|
| Current Assets |
|
19.99
+4.48%
|
19.13
-5.55%
|
20.26
-32.03%
|
29.80
|
| Cash Cash Equivalents And Short Term Investments |
|
8.87
-7.40%
|
9.58
-16.56%
|
11.48
-34.04%
|
17.41
|
| Cash And Cash Equivalents |
|
8.87
-7.40%
|
9.58
-16.56%
|
11.48
-34.04%
|
17.41
|
| Receivables |
|
6.53
+8.87%
|
6.00
+47.22%
|
4.07
-10.09%
|
4.53
|
| Accounts Receivable |
|
5.89
+7.13%
|
5.50
+35.92%
|
4.05
+13.67%
|
3.56
|
| Gross Accounts Receivable |
|
—
|
—
|
4.07
+13.68%
|
3.58
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
—
|
-0.02
-15.46%
|
-0.02
|
| Other Receivables |
|
0.64
+28.03%
|
0.50
+1630.13%
|
0.03
-97.03%
|
0.97
|
| Inventory |
|
3.68
+31.19%
|
2.80
-19.46%
|
3.48
-45.65%
|
6.40
|
| Raw Materials |
|
0.73
-11.51%
|
0.83
-55.72%
|
1.87
-51.48%
|
3.85
|
| Finished Goods |
|
2.95
+48.98%
|
1.98
+6.30%
|
1.86
-28.69%
|
2.61
|
| Prepaid Assets |
|
—
|
—
|
—
|
1.46
|
| Other Current Assets |
|
0.91
+21.16%
|
0.75
-38.45%
|
1.22
-16.40%
|
1.46
|
| Total Non Current Assets |
|
8.21
+1.55%
|
8.09
-1.45%
|
8.21
-34.52%
|
12.53
|
| Net PPE |
|
7.43
+2.35%
|
7.26
-1.29%
|
7.35
-4.19%
|
7.67
|
| Gross PPE |
|
11.49
+7.13%
|
10.73
+6.52%
|
10.07
-3.77%
|
10.47
|
| Accumulated Depreciation |
|
-4.07
-17.11%
|
-3.47
-27.62%
|
-2.72
+2.62%
|
-2.79
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.41
-1.81%
|
1.43
+1.52%
|
1.41
-3.06%
|
1.46
|
| Other Properties |
|
8.13
+10.70%
|
7.34
+9.47%
|
6.71
+1.66%
|
6.60
|
| Leases |
|
1.96
+0.28%
|
1.95
+0.00%
|
1.95
-19.06%
|
2.41
|
| Goodwill And Other Intangible Assets |
|
0.68
-6.22%
|
0.73
-3.19%
|
0.75
-4.17%
|
0.79
|
| Non Current Deferred Assets |
|
—
|
—
|
0.00
-100.00%
|
3.97
|
| Non Current Deferred Taxes Assets |
|
—
|
—
|
0.00
-100.00%
|
3.97
|
| Other Non Current Assets |
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
-3.56%
|
0.10
|
| Total Liabilities Net Minority Interest |
|
11.15
+7.18%
|
10.40
+28.34%
|
8.11
-26.34%
|
11.01
|
| Current Liabilities |
|
8.19
+13.78%
|
7.20
+61.68%
|
4.45
-35.99%
|
6.96
|
| Payables And Accrued Expenses |
|
7.63
+19.46%
|
6.39
+102.74%
|
3.15
-45.92%
|
5.82
|
| Payables |
|
2.27
+37.43%
|
1.65
+69.19%
|
0.98
-59.23%
|
2.39
|
| Accounts Payable |
|
2.27
+37.43%
|
1.65
+69.19%
|
0.98
-59.23%
|
2.39
|
| Current Accrued Expenses |
|
5.36
+13.20%
|
4.74
+117.79%
|
2.17
-36.65%
|
3.43
|
| Current Debt And Capital Lease Obligation |
|
0.54
-31.59%
|
0.79
-0.66%
|
0.79
-9.72%
|
0.88
|
| Current Debt |
|
—
|
0.27
-13.74%
|
0.31
-27.45%
|
0.43
|
| Current Capital Lease Obligation |
|
0.54
+4.36%
|
0.52
+7.95%
|
0.48
+7.58%
|
0.44
|
| Current Deferred Liabilities |
|
—
|
—
|
—
|
—
|
| Current Deferred Revenue |
|
—
|
—
|
—
|
—
|
| Other Current Liabilities |
|
0.03
-5.29%
|
0.03
-94.29%
|
0.51
+99.16%
|
0.26
|
| Total Non Current Liabilities Net Minority Interest |
|
2.96
-7.65%
|
3.20
-12.32%
|
3.65
-9.75%
|
4.05
|
| Long Term Debt And Capital Lease Obligation |
|
2.96
-7.65%
|
3.20
-12.32%
|
3.65
-9.75%
|
4.05
|
| Long Term Capital Lease Obligation |
|
2.96
-7.65%
|
3.20
-12.32%
|
3.65
-9.75%
|
4.05
|
| Stockholders Equity |
|
17.05
+1.39%
|
16.81
-17.39%
|
20.35
-35.03%
|
31.33
|
| Common Stock Equity |
|
17.05
+1.39%
|
16.81
-17.39%
|
20.35
-35.03%
|
31.33
|
| Capital Stock |
|
0.50
+0.84%
|
0.49
+0.59%
|
0.49
+0.47%
|
0.49
|
| Common Stock |
|
0.50
+0.84%
|
0.49
+0.59%
|
0.49
+0.47%
|
0.49
|
| Share Issued |
|
49.81
+0.84%
|
49.40
+0.62%
|
49.09
+0.47%
|
48.86
|
| Ordinary Shares Number |
|
46.37
+0.90%
|
45.96
+0.63%
|
45.67
+0.50%
|
45.44
|
| Treasury Shares Number |
|
3.44
+0.00%
|
3.44
+0.53%
|
3.42
+0.00%
|
3.42
|
| Additional Paid In Capital |
|
52.45
+5.78%
|
49.58
+5.45%
|
47.02
+6.25%
|
44.25
|
| Retained Earnings |
|
-32.02
-8.98%
|
-29.38
-26.02%
|
-23.31
-143.57%
|
-9.57
|
| Treasury Stock |
|
3.88
+0.00%
|
3.88
+1.01%
|
3.84
+0.00%
|
3.84
|
| Total Equity Gross Minority Interest |
|
17.05
+1.39%
|
16.81
-17.39%
|
20.35
-35.03%
|
31.33
|
| Total Capitalization |
|
17.05
+1.39%
|
16.81
-17.39%
|
20.35
-35.03%
|
31.33
|
| Working Capital |
|
11.79
-1.14%
|
11.93
-24.50%
|
15.80
-30.82%
|
22.84
|
| Invested Capital |
|
17.05
-0.22%
|
17.08
-17.34%
|
20.67
-34.92%
|
31.76
|
| Total Debt |
|
3.50
-12.37%
|
3.99
-10.24%
|
4.45
-9.74%
|
4.93
|
| Capital Lease Obligations |
|
3.50
-5.99%
|
3.72
-9.97%
|
4.13
-8.04%
|
4.49
|
| Net Tangible Assets |
|
16.36
+1.74%
|
16.08
-17.94%
|
19.60
-35.82%
|
30.54
|
| Tangible Book Value |
|
16.36
+1.74%
|
16.08
-17.94%
|
19.60
-35.82%
|
30.54
|
| Current Notes Payable |
|
0.00
-100.00%
|
0.27
-13.74%
|
0.31
-27.45%
|
0.43
|
| Inventories Adjustments Allowances |
|
-0.00
-0.85%
|
-0.00
+98.41%
|
-0.25
-316.81%
|
-0.06
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
0.46
+244.63%
|
-0.32
+93.47%
|
-4.89
+9.47%
|
-5.40
|
| Cash Flow From Continuing Operating Activities |
|
0.46
+244.63%
|
-0.32
+93.47%
|
-4.89
+9.47%
|
-5.40
|
| Net Income From Continuing Operations |
|
-2.64
+56.52%
|
-6.07
+55.85%
|
-13.74
-58.65%
|
-8.66
|
| Depreciation Amortization Depletion |
|
0.81
-8.78%
|
0.89
+2.08%
|
0.87
+48.24%
|
0.59
|
| Depreciation And Amortization |
|
0.81
-8.78%
|
0.89
+2.08%
|
0.87
+48.24%
|
0.59
|
| Other Non Cash Items |
|
-0.10
-140.20%
|
0.24
+1206.94%
|
-0.02
-110.35%
|
0.21
|
| Stock Based Compensation |
|
2.71
+3.42%
|
2.62
-5.23%
|
2.77
-10.08%
|
3.08
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
—
|
| Deferred Tax |
|
—
|
0.00
-100.00%
|
3.97
+295.81%
|
-2.03
|
| Deferred Income Tax |
|
—
|
0.00
-100.00%
|
3.97
+295.81%
|
-2.03
|
| Operating Gains Losses |
|
-0.01
-141.46%
|
0.02
-72.98%
|
0.06
|
—
|
| Gain Loss On Sale Of PPE |
|
-0.01
-141.46%
|
0.02
-72.98%
|
0.06
|
0.00
|
| Change In Working Capital |
|
-0.32
-116.16%
|
1.97
+64.04%
|
1.20
-14.23%
|
1.40
|
| Change In Receivables |
|
-0.49
+70.80%
|
-1.68
-466.49%
|
0.46
+307.64%
|
-0.22
|
| Changes In Account Receivables |
|
-0.49
+70.80%
|
-1.68
-244.53%
|
-0.49
-1530.29%
|
0.03
|
| Change In Inventory |
|
-0.87
-229.05%
|
0.68
-76.82%
|
2.92
+1079.32%
|
-0.30
|
| Change In Prepaid Assets |
|
-0.20
-189.35%
|
0.22
-9.26%
|
0.24
+743.06%
|
0.03
|
| Change In Payables And Accrued Expense |
|
1.24
-61.60%
|
3.24
+220.99%
|
-2.67
-254.93%
|
1.73
|
| Change In Accrued Expense |
|
0.63
-75.59%
|
2.56
+303.60%
|
-1.26
-323.83%
|
0.56
|
| Change In Payable |
|
0.62
-8.49%
|
0.67
+147.63%
|
-1.42
-221.67%
|
1.16
|
| Change In Account Payable |
|
0.62
-8.49%
|
0.67
+147.63%
|
-1.42
-221.67%
|
1.16
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
0.17
|
| Change In Other Current Liabilities |
|
-0.00
+99.68%
|
-0.48
-289.37%
|
0.26
+52.50%
|
0.17
|
| Investing Cash Flow |
|
-0.95
+28.75%
|
-1.33
-63.64%
|
-0.81
+70.92%
|
-2.80
|
| Cash Flow From Continuing Investing Activities |
|
-0.95
+28.75%
|
-1.33
-63.64%
|
-0.81
+70.92%
|
-2.80
|
| Net PPE Purchase And Sale |
|
-0.93
+28.17%
|
-1.29
-64.62%
|
-0.78
+71.64%
|
-2.76
|
| Purchase Of PPE |
|
-0.93
+28.13%
|
-1.30
-65.71%
|
-0.78
+71.64%
|
-2.76
|
| Sale Of PPE |
|
0.01
-21.18%
|
0.01
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.96
+28.70%
|
-1.34
-64.69%
|
-0.81
+70.92%
|
-2.80
|
| Net Intangibles Purchase And Sale |
|
-0.02
+45.66%
|
-0.04
-39.39%
|
-0.03
+21.88%
|
-0.04
|
| Purchase Of Intangibles |
|
-0.02
+45.66%
|
-0.04
-39.39%
|
-0.03
+21.88%
|
-0.04
|
| Financing Cash Flow |
|
-0.22
+10.94%
|
-0.25
-13.55%
|
-0.22
-178.31%
|
0.28
|
| Cash Flow From Continuing Financing Activities |
|
-0.22
+10.94%
|
-0.25
-13.55%
|
-0.22
-178.31%
|
0.28
|
| Net Issuance Payments Of Debt |
|
-0.38
-151.39%
|
-0.15
+30.94%
|
-0.22
-72.15%
|
-0.13
|
| Issuance Of Debt |
|
0.41
-16.57%
|
0.49
-13.74%
|
0.57
-27.89%
|
0.78
|
| Repayment Of Debt |
|
-0.79
-23.18%
|
-0.64
+18.54%
|
-0.78
+13.93%
|
-0.91
|
| Long Term Debt Issuance |
|
0.41
-16.57%
|
0.49
-13.74%
|
0.57
-27.89%
|
0.78
|
| Long Term Debt Payments |
|
-0.79
-23.18%
|
-0.64
+18.54%
|
-0.78
+13.93%
|
-0.91
|
| Net Long Term Debt Issuance |
|
-0.38
-151.39%
|
-0.15
+30.94%
|
-0.22
-72.15%
|
-0.13
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
-0.86
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
-0.86
|
| Net Common Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
0.41
|
| Common Stock Payments |
|
—
|
—
|
—
|
—
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
0.19
|
0.00
|
—
|
—
|
| Net Other Financing Charges |
|
-0.03
+71.72%
|
-0.10
-191.02%
|
-0.03
|
—
|
| Changes In Cash |
|
-0.71
+62.72%
|
-1.90
+67.92%
|
-5.93
+25.24%
|
-7.93
|
| Beginning Cash Position |
|
9.58
-16.56%
|
11.48
-34.04%
|
17.41
-31.29%
|
25.33
|
| End Cash Position |
|
8.87
-7.40%
|
9.58
-16.56%
|
11.48
-34.04%
|
17.41
|
| Free Cash Flow |
|
-0.49
+70.26%
|
-1.66
+70.89%
|
-5.71
+30.45%
|
-8.21
|
| Interest Paid Supplemental Data |
|
0.06
-22.78%
|
0.07
+41.51%
|
0.05
+78.42%
|
0.03
|
| Income Tax Paid Supplemental Data |
|
0.01
|
0.00
-100.00%
|
0.00
|
0.00
|
| Change In Income Tax Payable |
|
—
|
—
|
—
|
—
|
| Change In Tax Payable |
|
—
|
—
|
—
|
—
|
| Common Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
0.41
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
-100.00%
|
0.41
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-03 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-03-18 View
- 42026-03-18 View
- 42026-03-18 View
- 42026-03-18 View
- 8-K2026-03-16 View
- 10-K2026-03-12 View
- 8-K2026-03-12 View
- 42026-02-13 View
- 8-K2026-02-11 View
- 42026-01-15 View
- 8-K2026-01-12 View
- 42026-01-06 View
- 42026-01-05 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|